This week on MIP: Avanci's 5G pool, Newman transcript released
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: Avanci's 5G pool, Newman transcript released


We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Federal Circuit releases transcript from Newman oral argument

A special committee from the US Court of Appeals for the Federal Circuit released a transcript from an oral argument with Judge Pauline Newman’s counsel on Wednesday, August 16.

Gregory Dolin, senior litigation counsel from the New Civil Liberties Alliance, represented Newman at the July 13 hearing, which focused on whether her refusal to cooperate with Federal Circuit orders constituted misconduct.

Click here to read the full story.

Avanci unveils 5G patent platform for connected vehicles

Avanci announced the launch of its latest patent pool on Wednesday, August 16, with almost 60 participants signed up.

The licensing pool covers patented technologies that are essential to the 5G, 4G, 3G, and 2G standards in the connected vehicles industry.

Click here to read the full story.

Avanci chief: Huawei joining 5G platform was a ‘when, not if’

The CEO of Avanci has said Huawei signing up to its latest patent pool was a question of “when, not if” and that he is pleased to have the Chinese company on board.

Speaking to Managing IP, Kasim Alfalahi, who is based in the US, said: “I think it’s critical. I think it’s important. We are pleased that they [Huawei] joined.”

Click here to read the full story.

Samsung Bioepis fights to keep biosimilar on German market

The Munich Regional Court will weigh whether to ban sales of Samsung Bioepis’s biosimilar version of a rare blood disorder drug today, August 18.

Alexion, which is owned by UK drugmaker AstraZeneca, holds orphan drug exclusivity (ODE) rights for Soliris (eculizumab) for the treatment of multiple rare diseases.

Click here to read the full story.

Other articles published by Managing IP this week include:

Year in review: how Australian ruling has shaped computer patent landscape

Internet Archive could face major hurdles in latest case

Motivations behind £443m nChain IP deal revealed

Weekly take: Law firms jumping the gun with office mandates

Generics sound alarm over SPC owners' waiver ‘abuse’

Dentons demerger may not threaten IP work, but more reshuffles likely

Elsewhere in IP

Counterfeit crackdown

City of London Police seized £5 million ($6.4 million) worth of counterfeit merchandise from two shops in Camden, north London, on Tuesday, August 15.

The Police Intellectual Property Crime Unit (PIPCU) arrested three people on suspicion of distributing articles infringing trademarks.

The seized goods included almost 2,500 counterfeit football shirts as well as jewellery, handbags, and watches, PIPCU said.

Something in the rind

Parmesan producers are using microchips to track products and fight fakes, The Wall Street Journal found this week.

Parmesan is protected by an EU geographical indication and must be produced according to certain methods in the Parma and Reggio regions of Italy.

But the iconic product is frequently impersonated. In response, cheesemakers have started inserting micro transponders the size of a grain of salt in the rinds of their products.

Consumers can use the microchips, which are embedded into QR code labels, to track the origins of their cheese.

When the music stops

Record labels including Sony and Universal are the latest copyright owners to sue the Internet Archive, it emerged last Friday, August 11.

The labels claim the online library has infringed their copyright by making old recordings of 78 rpm records available online.

Brewster Kahle, digital librarian at the Internet Archive, said the organisation was taking the suit “seriously” but defended its “Great 78 Project”, which he said was designed to “bring free public access to a largely forgotten but culturally important medium”.

The Internet Archive lost a high-profile suit against book publishers over its digital lending scheme earlier this year.

Sumitomo deal

Herbert Smith Freehills advised Sumitomo on the intellectual property aspect of a deal to invest in Vodafone’s digital economy spin-out, the firm announced yesterday, August 17.

Sumitomo announced in May it planned to invest in Dabco, a Vodafone-owned digital platform that enables autonomous identification and communication between connected devices.

Andrew Moir, global head of cyber and data security at HSF, advised on IP law aspects of the deal, supported by Jess Welborn in London.

Chat bot wars

The New York Times is mulling a copyright suit against Open AI, the company behind ChatGPT, over the use of its news content to train the language model.

The parties are currently involved in talks over a potential licence but the relationship is strained to the point that lawyers for the news publisher are considering legal action, two sources with direct knowledge of the discussions told public radio network NPR.

AI revolution?

CMS UK will partner with software company IPDefine to use artificial intelligence tools to detect patent infringement and provide patent validity analysis, the firm announced yesterday, August 17.

"Combining IPDefine’s AI tools with CMS’ market-leading IP team specialised in IP commercialisation, due diligence, licensing and patent litigation, we will be able to support our clients' transition to IP 2.0," said Toby Sears, partner at CMS, on LinkedIn.

That's it for today, see you again next week.

more from across site and ros bottom lb

More from across our site

The firm was among multiple winners at a record-breaking 2024 ceremony held in London on April 11
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!
Increased and new patent fees could affect prosecution strategies for law firms and companies, according to sources
Five former Oblon lawyers felt that joining Merchant & Gould would help them offer the right prices to entice clients
The UK may not be a UPC member but its firms are still acting in proceedings, with Carpmaels among the most prominent
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
The Court of Appeal has dismissed an appeal filed by Ocado, in what was a key test for transparency at the new court
Each week Managing IP speaks to a different IP lawyer or professional about their life and career
INTA is calling out ‘immoral’ unregistered attendees at the association’s annual meeting, but the debate is more nuanced
Gift this article